Navigation Links
Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
Date:5/11/2009

approved lapatinib in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2/ErbB2 and who have received prior therapy including an anthracycline, a taxane and trastuzumab. On June 10, 2008, the European Commission granted a conditional marketing authorization for lapatinib in all 27 European Union (E.U.) member states. Other countries in which lapatinib is authorized for marketing include Japan, Australia, India, Brazil, Russia, Switzerland, Turkey, South Korea, Taiwan and others around the world. Registration dossiers for lapatinib have been filed in Canada, China, Mexico and a number of countries in Latin America, Middle East, Africa and Asia Pacific.

For more information see full prescribing information.

About AVODART(R) (dutasteride)

Dutasteride inhibits both type 1 and type 2 5-alpha reductase isoenzymes, which are responsible for converting testosterone to dihydrotestosterone (DHT), the most potent male hormone in the prostate. Basic science studies indicate that both types of the enzyme - type 1 and type 2 - are present in prostate tissue and that the type 1 form is increased in prostate cancer, including high grade cancer. The clinical significance of the in vitro dual inhibition of type 1 and type 2 5-alpha reductase isoenzymes has not been established.

Dutasteride is indicated for the treatment of moderate-to-severe symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It has been shown to improve urinary symptoms, reduce the risk of acute urinary retention (AUR), and the risk of BPH-related surgery.

Women and children should not take dutasteride. Women who are or could become pregnant should not handle dutasteride due to the potential risk of a specific birth defect. Blood should not be donated until at least six months following the last
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... Texas (PRWEB) October 20, 2014 ... development for Partial Seizure, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Partial Seizure and special features on late-stage and ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 SweetDressy.com, a ... recently announced its promotion for long evening dresses ... enjoy the special offer; the current discount is up ... of the industry pioneers in the fashion field. Its ... for ladies dwelling in various parts of the world. ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Stephen T. Greenberg, ... been nominated for the 10th consecutive year as one of ... Dr. Greenberg was also been nominated as the best provider ... also nominated as best Day Spa and best Laser Treatment ... December 14th and readers can vote for the contest once ...
(Date:10/19/2014)... is a systemic disease that causes inflammation in ... affected members of the ancient Egyptian royal families. ... & Rheumatology , a journal of the American ... instead a degenerative spinal condition called diffuse idiopathic ... the 18th to early 20th Dynasties. , ...
Breaking Medicine News(10 mins):Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2
... A new $10 million research project which aims at ... launched by the Preventative Health //Flagship, a CSIRO program ... on the early detection of Alzheimer's disease, which currently ... researchers will be using Positron Emission Tomography (PET scans) ...
... screening appears to be increasing among Veterans Affairs patients, ... screening procedures// , according to a report. A second ... with other illnesses and reduced life expectancies may not ... harmed, but continue to be screened at high rates. ...
... have come up with incriminating evidence that warns non-vegetarians who ... study has pointed out that eating more than one and ... developing hormone related breast cancer and another study that ... heart from heart diseases except for vitamin C which seems ...
... the remedy of choice for treatment of influenza is causing ... side effects, regulators said today. ,The U.S. FDA has ... and mental disorientation were reported from Japan by people who ... reports concerned children. ,The new label approved by ...
... patients will adhere more closely to their medication regimens ... care program that includes patient education, specially packaged medications, ... ,The “Federal Study of Adherence to Medications in the ... Health-System Pharmacists (ASHP) Research and Education Foundation, followed 200 ...
... onset of diabetes today is linked to high stress levels. ... diet, hypertension and lack of physical exercise. The number of ... crores and about 7.2 lakh lives are claimed by this ... realize consequences of this deadly disease. , ,Because ...
Cached Medicine News:Health News:Studies Examine Colorectal Cancer Screening Rates 2Health News:Studies Examine Colorectal Cancer Screening Rates 3Health News:Studies Examine Colorectal Cancer Screening Rates 4Health News:Red alert to women against red meat consumption 2Health News:Caution:Tamiflu ‘tames’ flu but psychiatric side effects now report 2Health News:Pharmacy Care Program Can Increase Medication Adherence in Elderly 2Health News:Pharmacy Care Program Can Increase Medication Adherence in Elderly 3Health News:Diabetes Linked to High Stress Levels 2
(Date:10/17/2014)... 17, 2014 With the recent changes ... has come across several challenges in creating and ... globalization.  The Medical Affairs ... to providing benchmarking and best practices across critical ... a service composed of three stages: 1) member-driven ...
(Date:10/17/2014)... 17, 2014 ... announced the addition of the  "China Interventional ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... China impacted by ... consumption concept, dietary habit, way of working ...
(Date:10/17/2014)... , October 17, 2014 ... Pharmaceuticals Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... CPRX). Free research on these five companies can be ... markets on Thursday, October 16, 2014, ended on a ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5
... Disease Indication for HUMIRA Provides Patients with Visible, ... Chronic Autoimmune Disease, ABBOTT PARK, Ill., Jan. ... it has received U.S. Food and Drug Administration ... for adult patients,with moderate to severe chronic plaque ...
... Jan. 17 GeoVax Labs, Inc. (OTC,Bulletin Board: ... it has been named a "2008 Deal of ... recognized GeoVax for receiving a,$15 million IPCAVD (Integrated ... of Health (NIH) in October,2007. The award will ...
Cached Medicine Technology:Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 2Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 3Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 4Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 5Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 6Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis 7GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 2GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 3GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry 4
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
... With its simplified operations, the ... patient, clinic or satellite lab testing. ... offers multi-language software. Built on ... technology, the KX-21N features a completely ...
... Tubes were designed for ease of use, ... capillary blood sample is collected. The wider-diameter ... features an integrated collection scoop and improved ... tubes is available for hematology and chemistry ...
... The Identity pacemaker family, which ... provides clinicians with the most advanced ... AF Suppression algorithm, the first and ... to suppress atrial fibrillation (AF). The ...
Medicine Products: